FdaApplication
ANDA 204095
Identifiers
- fda_app_no: ANDA204095
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2015-06-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products